Telpegfilgrastim for neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 1 Dec 2024: Trial started, NCT06857292
  2. 4 Mar 2025: Trial registered, NCT06857292

The trials

NCT06857292: Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy

State
Under way
Phase
Phase 2
People
97 planned
Started
1 Dec 2024
Primary completion
Dec 2025
Arms
Experimental group
Results
None posted
  1. 1 Dec 2024: Trial started
  2. 4 Mar 2025: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Telpegfilgrastim Injection.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.